Mylan Investigations Mount as West Virginia Opens Fraud Probe

Updated on
  • West Virginia AG seeks court order on rebate documents
  • Morrisey calls EpiPen’s 500 percent price hike ‘outrageous’

Mylan Plans Half-Priced Generic Version of EpiPen

Mylan NV, already under fire from patients over the rising price of its EpiPen allergy shots, is facing a growing number of questions from lawmakers and law enforcement after the state of West Virginia launched a Medicaid fraud investigation into the drugmaker’s pricing Tuesday.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.